Editorial Process

Our Process

All monographs, guides, and protocol documentation are produced through a multi-stage editorial workflow:

1. Literature review — We survey the peer-reviewed literature for each compound, prioritizing primary research published in indexed journals with established impact factors. We do not cite press releases, unreviewed pre-prints, manufacturer claims, or anecdotal reports as primary evidence.
2. Drafting — Content is drafted by our editorial team, drawing exclusively from the literature identified during review. Every factual claim is tied to a specific citation.
3. Internal review — Each draft undergoes review for scientific accuracy, citation integrity, methodological context, language precision, and completeness. The reviewer checks that claims are supported by the cited evidence, that animal and in vitro findings are distinguished from human clinical data, and that speculative language is used where evidence is preliminary.
4. Publication — Approved content is published with clear attribution, publication date, and review date displayed in the article header.
5. Ongoing maintenance — Published content is revisited on a regular cadence to incorporate new research, correct errors, and update clinical trial statuses.

Source Policy

We maintain strict sourcing standards across all research content:

• Primary sources only — We cite original peer-reviewed research papers, not secondary summaries or derivative content.
• DOI linking — Every citation includes a Digital Object Identifier (DOI) link where available, providing permanent access to the source material.
• Full attribution — Author lists (or "et al." for groups larger than four), journal name, and publication year are included for every reference.
• Inline citation — Key claims are cited at the point of reference, not only in an end-of-article bibliography.
• Recency preference — We prioritize recent research (last 10 years) while including foundational studies where relevant.
• Negative findings included — We report study limitations, negative results, and discontinued research alongside positive findings. Our content reflects the current state of the literature, not a curated selection of favorable results.

Corrections Policy

We are committed to accuracy and will promptly correct errors when identified:

• Minor corrections (typos, formatting, broken links) are fixed immediately and the update date is revised.
• Substantive corrections (factual errors, misrepresented findings, incorrect citations) include a correction note at the top of the article explaining what was changed and why.
• Retractions — If a cited study is retracted, we update the relevant content within 30 days, noting the retraction and adjusting conclusions as needed.

To report an error or suggest a correction, contact us at research@alpineresearchlabs.com.

Review Cadence

Published content is reviewed on a quarterly basis. Articles are updated when:

• Significant new research is published that changes the scientific understanding of a compound.
• Corrections are needed based on reader feedback or internal review.
• Clinical trial status changes (e.g., new phases begun or completed).
• Regulatory developments affect the research landscape.

Every article displays both its original publication date and the date of its most recent review, so readers can assess content currency at a glance.